京都大学iPS細胞研究所 増殖分化機構研究部門 幹細胞医学分野

JAPANESE

Repeat expansion diseases

TOP > Repeat expansion diseases

Overview

Repeat expansion diseases refer to a group of genetic diseases caused by an abnormal increase in the number of repeats of a gene in a specific genomic region. In these diseases, certain sequences in the genes are repeated more than normal, and this causes the pathogenesis of the disease.
Major repeat expansion diseases include Huntington's disease, myotonic dystrophy, fragile X-associated tremor/ataxia syndrome, and some forms of spinocerebellar ataxia.

The number of repeats varies with the disease, but can be in the thousands. 
At present, more than 50 diseases have been discovered, many of which are brain nerve diseases or muscular diseases.

Characteristics

It is considered that abnormal repeats interfere with the normal functioning of genetic molecules, which leads to cellular dysfunction and tissue abnormalities. It is also known that the clinical symptoms of some of these diseases may depend on the number of repeats and that the number of repeats may increase with successive generations.

Research status

Possible mechanisms of disease include toxicity induced by repeat RNA, toxicity of peptides produced by non-ATG-dependent translations associated with repeats, and changes in gene expression, or abnormal splicing due to epigenetic influences.

Disease models using iPS cells can directly reflect information about the human genome, such as the length of repeat expansions and the position of insertion.

Clone name Name of disease Age at time of collection Sex Somatic cell Clinical information
ALS60E1 Neuronal intranuclear inclusion disease (NIID) 63 M fibroblast view details
NIHDS2E1 Neuronal intranuclear inclusion disease (NIID) 73 M fibroblast view details
NIHDS3EL1 Neuronal intranuclear inclusion disease (NIID) 69 F PBMC view details
NIHDS4EL1 Neuronal intranuclear inclusion disease (NIID) 37 M PBMC view details
FX1EL3 Fragile X syndrome 46 F PBMC view details
FX2EL16 Fragile X syndrome 17 M PBMC view details
FX6EL1 Fragile X syndrome 23 M PBMC view details
FX8EL1 Fragile X syndrome 4 M PBMC view details
FXTAS1EL1 Fragile X-associated tremor/ataxia syndrome (FXTAS) 82 M PBMC view details
FXTAS2EL1 Fragile X-associated tremor/ataxia syndrome (FXTAS) 58 M PBMC view details
MyD1 ⑩/HPS1032 Myotonic dystrophy 30s M PBMC view details
MyD2 ②/HPS1051 Myotonic dystrophy 30s F PBMC view details
MyD5 ⑬/HPS1052 Myotonic dystrophy 30s M PBMC view details
MyD3 ⑦/HPS1033 Myotonic dystrophy 30s M PBMC view details
HD1E6 Huntington's disease 60s M fibroblast view details
SCD37EL2 Spinocerebellar ataxia type 31 54 F PBMC view details
SCD4 E2 Spinocerebellar ataxia type 36 64 M fibroblast view details
SCD10 9E/HPS0422 Spinocerebellar ataxia type 36 60 M PBMC view details
SCD20 E1 Spinocerebellar ataxia type 36 65 F PBMC view details
CANVAS1EL1 cerebellar ataxia with neuropathy and vestibular areflexia syndrome 68 M PBMC view details
EPI5EL3 Benign adult familial myoclonus epilepsy (BAFME) 63 F PBMC view details
EPI18EL2 Benign adult familial myoclonus epilepsy (BAFME) 43 M PBMC view details
EPI20EL2/HPS3911 Benign adult familial myoclonus epilepsy (BAFME) 15 M PBMC view details
EPI21EL2/HPS3914 Benign adult familial myoclonus epilepsy (BAFME) 15 M PBMC view details

Back